# FDA Inspection 717283 - Janssen Vaccines, Zweigniederlassung der Cilag GmbH International - February 25, 2011

Source: https://www.keypedia.com/records/fda_inspections/janssen-vaccines-zweigniederlassung-der-cilag-gmbh-international/ef28c55f-9d6d-48d8-84e1-33a0d690e717
Source feed: FDA_Inspections

> FDA Inspection 717283 for Janssen Vaccines, Zweigniederlassung der Cilag GmbH International on February 25, 2011. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 717283
- Company Name: Janssen Vaccines, Zweigniederlassung der Cilag GmbH International
- Inspection Date: 2011-02-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 819593 - 2012-12-07](https://www.keypedia.com/records/fda_inspections/janssen-vaccines-zweigniederlassung-der-cilag-gmbh-international/12b73391-26c1-4218-b93f-143d12a2c83a)
- [FDA Inspection 618252 - 2009-01-23](https://www.keypedia.com/records/fda_inspections/janssen-vaccines-zweigniederlassung-der-cilag-gmbh-international/55cf564a-f18c-44a5-897e-401576778657)

Company: https://www.keypedia.com/companies/janssen-vaccines-zweigniederlassung-der-cilag-gmbh-international/f1be536a-aa34-43b6-afde-568c99db0c81

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d